The farnesylated SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) Ykt6 mediates protein palmitoylation at the yeast vacuole by means of its amino-terminal longin domain. Ykt6 is localized equally to membranes and the cytosol, although it is unclear how this distribution is mediated. We now show that Ykt6 is released efficiently from vacuoles during an early stage of yeast vacuole fusion. This release is dependent on the disassembly of vacuolar SNAREs (priming). In recent literature, it had been demonstrated for mammalian Ykt6 that the membrane-bound form is both palmitoylated and farnesylated at its carboxy-terminal CAAX box, whereas soluble Ykt6 is only farnesylated. In agreement with this, we find that yeast Ykt6 becomes palmitoylated in vitro at its C-terminal CAAX motif. Mutagenesis of the potential palmitoylation site in yeast Ykt6 prevents stable membrane association and is lethal. On the basis of these and other findings, we speculate that Ykt6 is released from membranes by depalmitoylation. Such a mechanism could enable recycling of this lipid-anchored SNARE from the vacuole independent of retrograde transport.
INTRODUCTION
Membrane fusion along the endocytic and secretory pathways is tightly regulated. Rab guanosine triphosphate hydrolases (GTPases) and tethering complexes control membrane docking before N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) from opposing membranes form tight fourhelix bundles (trans-SNARE complexes) that drive fusion (Bonifacino & Glick, 2004) . Most SNAREs are permanently anchored to membranes by means of carboxy-terminal transmembrane domains, although some exceptions exist, suggesting that regulation of SNARE association to membranes may impart an additional level of fusion control (Dietrich et al, 2003) .
The farnesylated SNARE Ykt6 has been found in both cytosolic and membrane-associated pools (McNew et al, 1997) , implicating that it cycles in a regulated manner. In contrast to many other SNAREs, Ykt6 is involved in multiple intracellular fusion reactions (reviewed by Rossi et al, 2004) . On the yeast vacuole, Ykt6 is needed for homotypic fusion (Ungermann et al, 1999) , but does not seem to be present in the trans-SNARE complex that forms during vacuole docking (Dietrich et al, unpublished data) . Recently, it was shown that Ykt6 is required for palmitoylation of the fusion factor Vac8 . Ykt6 binds palmitoyl-CoA (Pal-CoA) by means of its conserved aminoterminal longin domain and mediates Vac8 acylation in an early stage of vacuole fusion.
Ykt6 has a C-terminal CAAX motif that contains two conserved cysteines (CCIIM; Tochio et al, 2001) , and the more C-terminal cysteine is farnesylated (Yalovsky et al, 1999; Long et al, 2002) . As farnesylation alone is not sufficient to anchor proteins firmly to membranes (Yalovsky et al, 1999) , we suggested that palmitoylation of the second cysteine could contribute to stable membrane localization, similar to Ras GTPase isoforms (Hancock, 2003) . Here, we show that yeast Ykt6 is palmitoylated at the CAAX box cysteines as also observed for mammalian Ykt6 (Fukasawa et al, 2004; Veit, 2004) , and this in combination with farnesylation confers tight membrane binding. Strikingly, the stable membrane association of Ykt6 gets lost during the vacuole fusion reaction, as Ykt6 gets efficiently released from vacuoles in a primingdependant manner. This indicates that a palmitoylation/depalmitoylation cycle might dynamically control the localization of the widely distributed SNARE protein, thereby regulating the intracellular membrane flow.
RESULTS AND DISCUSSION Ykt6 is palmitoylated in vitro
When analysing in vitro acylation of Vac8 in the presence of Ykt6, both purified from Escherichia coli, we observed acylation of Ykt6 ( Fig 1A; supplementary Fig S1 online) . Importantly, whereas denatured Vac8 does not affect Ykt6 acylation (data not shown), denaturation of Ykt6 prevents palmitoylation of both proteins ( Fig 1A) . This verifies the specificity of the two acylation events and demonstrates that the proper folding of Ykt6 is of crucial importance for both reactions. Ykt6 contains three cysteines: one nonconserved cysteine within the longin domain, and two conserved cysteines within the C-terminal CAAX box (see Fig 1C) . When the C-terminal cysteines were mutated to alanines, acylation of Ykt6 was completely abolished (Fig 1B) , suggesting that they are the targets of palmitoylation. As the cysteine residue nearest the C-terminal is farnesylated in vivo (Long et al, 2002) , our data point to the upstream cysteine as the relevant palmitoylated residue, although it is possible that both sites are used in vitro. Fukasawa et al (2004) reported that the equivalent cysteine in mammalian Ykt6 also gets palmitoylated in vivo, indicating that palmitoylation of the Ykt6 CAAX box is conserved in evolution.
Analysis of purified yeast Ykt6
To address whether dual lipidation of yeast Ykt6 occurs in vivo, we purified wild-type protein and a mutant lacking both C-terminal cysteines (Ykt6-AAIIM) from yeast. The wild-type protein should receive several modifications: farnesylation at C197, which is followed by the removal of the IIM peptide and carboxymethylation (Schmidt et al, 1998) , and potential palmitoylation. We expected these modifications to be reflected in the migration pattern on SDS-polyacrylamide gel electrophoresis (SDS-PAGE). For our analysis, we purified tagged Ykt6 from yeast and analysed its migration on gradient gels (Fig 2) . Under reducing conditions, which trigger cleavage of thioester-bound palmitate (Veit et al, 2001) , both wild-type and mutant Ykt6 ran as distinct bands, although with different mobilities (Ykt6-WT: 25 kDa; Ykt6-AAIIM: 27 kDa). This difference is most probably due to the farnesylation and proteolytic processing of the CCIIM motif of Ykt6-WT. Strikingly, nonreducing conditions, which should preserve a palmitate modification, yielded a very different picture: whereas Ykt6-AAIIM, which cannot get acylated, did not change its mobility, Ykt6-WT separated into three distinct bands. As prenyl anchors (which are attached to proteins by thioether bonds) are not affected by reducing conditions, we ascribe the enhanced mobility to palmitoylation of the CAAX box of Ykt6.
Palmitoylation of Ykt6 is essential for viability
To evaluate the functional consequences of modifications in the CAAX box of Ykt6, we determined whether both C-terminal cysteines are essential for yeast survival. As shown in Fig 3A, wildtype Ykt6, but none of the CAAX box mutants, rescued growth of a ykt6 deletion strain. Thus, both the farnesylated cysteine (C197) and the presumably palmitoylated cysteine (C196) are essential for yeast viability and Ykt6 function in vivo. This indicates that dual lipidation is an essential feature of Ykt6 function.
Farnesylation alone is not sufficient to anchor a protein to a membrane (Yalovsky et al, 1999) . To test whether both CAAX box cysteines are required for membrane localization, we analysed membrane association of the mutants. For this, we expressed green fluorescent protein (GFP)-tagged wild-type or mutant Ykt6 Red. Red. Nonred.
Nonred.
Fig 2 | Gel mobility of purified Ykt6 and the AAIIM mutant. His-Ykt6-WT and His-Ykt6-AAIIM were purified from Gal-overproducing strains as described in Methods, and analysed by reducing or nonreducing 4-10% gradient gels (Invitrogen, Karlsruhe, Germany). Indicated bands were identified by MALDI mass spectrometry.
Ykt6 release at vacuoles L.E.P. Dietrich et al in a wild-type background (Fig 3B) , and found that removal of both cysteines abolished Ykt6 membrane localization (Fig 3C) . Exchange of the single cysteines also interfered with membrane binding, indicating that the combination of palmitoylation and farnesylation stably anchors Ykt6 to membranes.
Ykt6 release at the yeast vacuole
The SNARE Ykt6 is present in a soluble and a membrane-bound pool (McNew et al, 1997; Hasegawa et al, 2003; Fukasawa et al, 2004) . The dynamics of Ykt6 that establish these pools are not understood. Here, we demonstrate that Ykt6 is released efficiently from yeast vacuoles on incubation under fusion conditions (Fig 4) . This was not due to degradation, as we recovered the protein in the reaction supernatant (Fig 4A) . Release was complete within the first 10 min of the fusion reaction (Fig 4B) , which is coincident with Sec17 release, a marker for an early stage of the fusion reaction (priming; Mayer et al, 1996) . As Ykt6 is localized to multiple membranes (McNew et al, 1997; Zhang & Hong, 2001; Hasegawa et al, 2003) , and vacuole preparations are contaminated by endoplasmic reticulum (ER), endosome and Golgi membranes (our unpublished observations), we analysed specificity of the release. Antibodies that block vacuole SNARE complex (Haas, 1995) . The total lysate was cleared by centrifugation at 400g (5 min, 4 1C) and the resulting supernatant was centrifuged for 15 min at 13,000g. The resulting 'P13' pellets were collected and diluted to 0.3 mg/ml in PS buffer containing 0.1 Â PIC. Proteins were analysed as above. isolated vacuoles were heated in sample buffer in the absence or presence of b-mercaptoethanol (b-ME). Left: protease-deficient vacuoles were incubated in standard fusion reactions (45 ml), in the absence or presence of ATP for 30 min. Vacuole membranes were re-isolated (pellet) and supernatants were TCA-precipitated (Sup.). In both experiments, Ykt6 was analysed by nonreducing 12% SDS-PAGE (10-cm-long gel). Note that mobility of Ykt6 forms depends on the gel system used.
Ykt6 release at vacuoles L.E.P. Dietrich et al disassembly and Sec17 release also inhibited Ykt6 release (Fig 4C) , confirming simultaneously that this event is vacuole specific and dependent on vacuole priming. Before priming (that is, on freshly isolated vacuoles in the absence of ATP), vacuolebound Ykt6 resisted carbonate extraction (not shown), suggesting that it is the dual lipid anchor and not protein-protein interactions that confers tight membrane binding. Next, we asked whether we could correlate the differences in Ykt6 mobility, shown in Fig 2, with the release reaction. Indeed, two forms of wild-type Ykt6 can be resolved when vacuoles are lysed in nonreducing sample buffer, and one form disappears when reducing conditions are used (Fig 4D, right) . When vacuoles are incubated under fusion conditions, both forms are detected on the membrane, but, strikingly, only the lower form is released into the reaction supernatant (Fig 4D, left) . This indicates that only the depalmitoylated form is released. These observations are in agreement with a recent report stating that palmitoylated Ykt6 is only found in membrane fractions (Fukasawa et al, 2004) . Would other vacuolar SNAREs undergo a similar release if equipped with the CCIIM-anchoring motif of Ykt6? To answer this question, we replaced the transmembrane domains of the second vacuolar R-SNARE, Nyv1, and the Q-SNARE Vam3 with CCIIM motifs. These CCIIM fusion proteins localized to vacuole membranes, as determined by cellular fractionation (Fig 5A) . However, whereas Ykt6 was released from vacuoles during an ATP incubation, both Vam3-CCIIM and Nyv1-CCIIM remained membrane bound (Fig 5B) . Thus, release from vacuoles is specific to Ykt6, and not due to the presence of a CCIIM anchor alone. A large portion of the released Ykt6 is soluble, as it can be recovered from the high-speed supernatant (Fig 5C) .
Taking into consideration that cytosolic mammalian Ykt6 is not palmitoylated (Fukasawa et al, 2004) , mammalian Ykt6 can functionally replace yeast Ykt6 (McNew et al, 1997) and yeast Ykt6 localizes to the same compartments as neuronal Ykt6 (Hasegawa et al, 2003) , our data suggest that partitioning between cytosol and membranes is specific for Ykt6. Depalmitoylation might be responsible for Ykt6 dissociation from membranes.
We therefore propose that the release of Ykt6 is coupled to depalmitoylation at the C-terminal CAAX box, completing a palmitoylation/depalmitoylation cycle of Ykt6. Importantly, Vac8 acylation on isolated vacuoles is restricted to early stages of the fusion reaction (Veit et al, 2001) , suggesting a connection between Ykt6 release and Vac8 acylation. On the basis of this observation and our findings that (i) antibodies to Ykt6 do not inhibit fusion with the same kinetics as other SNARE antibodies and (ii) Ykt6 is needed before but not during trans-SNARE complex formation (Dietrich et al, unpublished data) , we propose the following model: contrary to its role at other organelles, Ykt6 does not function as a SNARE in vacuole fusion. Rather, it is specifically targeted to the vacuole by virtue of its SNARE domain, where it palmitoylates Vac8, and is released, facilitating its recycling (Fig 5D) .
On the basis of these observations, we speculate that not only membrane binding, but also Ykt6 release are highly regulated events. In the cytosol, Ykt6 exists in a closed conformation (Hasegawa et al, 2003) , potentially accommodating its farnesyl anchor within the N-terminal longin domain (Tochio et al, 2001; Hasegawa et al, 2004) . This seems to be an essential intermediate of Ykt6, as mutations that block the interaction of were prepared for vacuole preparations, but before centrifugation, aliquots of total cell extract (total) were removed and placed into sample buffer or centrifuged (30 min, 100,000g, 4 1C). The supernatant fraction was TCA-precipitated. Proteins were analysed as before. Total and vacuoles, 30 mg each; supernatant was obtained from 150 mg of total. (B) Ykt6 release assay, performed as in Fig 4A. (C) Solubility of released Ykt6. Following the ATP-dependent release, reaction samples were centrifuged (10 min, 14,000g, 4 1C). Half of the supernatant was TCA-precipitated (S14), and the other half was centrifuged again (30 min, 100,000g, 4 1C). The resulting supernatant (S100) was TCA-precipitated. Pellets from each centrifugation (P14 and P100) were resuspended in sample buffer and analysed as before. Ykt6 release at vacuoles L.E.P. Dietrich et al N and C termini also affect yeast viability (Tochio et al, 2001) . At the membrane, closed Ykt6 may be recognized by a receptor that triggers opening of the protein and membrane insertion of its farnesyl anchor. Subsequent palmitoylation would then ensure its stable anchoring. As Ykt6 can bind Pal-CoA by means of its N-terminal longin domain , is able to palmitoylate Vac8 and is efficiently acylated in vitro (Fig 1) , we speculate that Ykt6 palmitoylates itself, as also suggested for human Ykt6 (Veit, 2004) . Release of Ykt6 from the vacuole is probably associated with its deacylation, and would be consistent with the observation that only membrane-bound Ykt6 is palmitoylated in mammalian cells (Fukasawa et al, 2004) . So far, only one thioesterase, Apt1, has been identified in yeast. It is a nonessential cytosolic protein that specifically depalmitoylates G a (Duncan & Gilman, 2002 ). An apt1 deletion does not affect any of the Vac8-and Ykt6-related functions we assayed for, and does not affect Ykt6 release (supplementary Fig S2 online) . It is possible that another Ykt6-specific thioesterase resides on the vacuole or that deacylation of Ykt6 could directly be coupled to, for example, Vac8 acylation. In this context, it is noteworthy that Ykt6 release and Vac8 acylation both occur early in the vacuole fusion reaction, indicating a possible palmitate transfer from Ykt6 to Vac8 (Fig 5D; Veit et al,  2001 ). This, however, does not exclude the existence of other palmitate acceptors at the vacuole, as vacuoles deleted for vac8 still release Ykt6 (not shown).
Our data suggest that a dynamic palmitoylation/depalmitoylation cycle controls Ykt6 distribution. We propose two scenarios of how this cycle might be used in the endomembrane system: (i) Ykt6 might cycle on and off each of its target membranes (that is, Golgi, endosome, vacuole), resulting in multiple local cycles (reviewed by Rossi et al, 2004) , and (ii) Ykt6 might enter specifically at the ER and eventually be released from vacuoles, constituting one cycle through the endomembrane system: farnesylated proteins are usually modified at their CAAX box by removal of their C-terminal IIM residues and carboxymethylation. The Caax protease Rce1 is an ER-localized enzyme (Schmidt et al, 1998) , suggesting that newly synthesized farnesylated proteins, including Ykt6, initially associate with the ER. The ER could also be the site where subsequent Ykt6 acylation occurs to ensure stable membrane binding. From the ER, Ykt6 could move through the Golgi to the yeast vacuole as the terminal organelle, from which it is released (Fig 4) . Release would complete the Ykt6 cycle through the endomembrane system, facilitating its recycling from the vacuole independent of degradation or retrograde transport (Bryant et al, 1998) . This would be consistent with the behaviour of other prenylated proteins, such as Ras-like small GTPases, which cycle between membranes and cytosol to control their activation and localization (Segev, 2001) . We speculate that the dynamic distribution of the most conserved SNARE, Ykt6, contributes to the control of the cellular membrane flux.
METHODS
Biochemical reagents and antibodies. All biochemical reagents were purchased from Sigma (Steinheim, Germany) or Roth (Karlsruhe, Germany), unless indicated. All reagents added to vacuoles were prepared in, or dialysed into, PS (10-20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol) buffer. Polyclonal antibodies were as described previously .
Yeast strains and molecular biology. Saccharomyces cerevisiae strains used are listed in supplementary Table S1 online. Yeast strains were cultured in YPD medium, except where indicated. Details on yeast strains and plasmids, and recombinant proteins are included in the supplementary information online. Purification of His-Ykt6 from yeast. CUY437 (BY4743 pep4DHHIS3; pGALPatG1L-His-YKT6) or CUY569 (BY4743 pep4DHHIS3; pGALPatG1L-His-Ykt6 AAIIM ) strains were grown overnight in 2 l of SGC-ura-his to an OD 600 of 2. Cells were collected by centrifugation (10 min, 5,000g), washed in lysis buffer (20 mM PIPES-KOH, pH 6.8, 125 mM KCl, 0.5 Â PIC, 1 mM PMSF) and frozen as droplets in liquid nitrogen. Cells were then opened by grinding in a powder mill in liquid nitrogen. The cell powder was thawed, diluted in 2 ml of lysis buffer and centrifuged (30 min, 100,000g, 41C). The soluble supernatant was loaded onto Ni-NTA agarose (Qiagen, Hilden, Germany) and incubated overnight at 4 1C on a nutator. Beads were washed with lysis buffer containing 10 mM imidazole, and bound proteins were eluted in a step elution in 300 mM imidazole. The eluate was analysed by gradient nonreducing 4-10% gels and Coomassie staining. In vitro palmitoylation. In vitro palmitoylation with [ 3 H]Pal-CoA using recombinant Vac8-GST and His 6 -Ykt6 was as described previously . Vacuole isolation. Vacuoles were isolated from the indicated yeast strains by DEAE-dextran lysis and Ficoll gradient centrifugation as described previously (Haas, 1995) . Supplementary information is available at EMBO reports online (http://www.emboreports.org).
